Dr. Nikhil Suresh Ghadyalpatil

Dr. Nikhil Suresh Ghadyalpatil is a Senior Consultant in Medical Oncology at Apollo Hospital, Jubilee Hills, Hyderabad, with over 18 years of specialised clinical experience in cancer care. He holds advanced qualifications including MBBS, MD in Internal Medicine, and DM in Medical Oncology, along with membership in the National Academy of Medical Sciences (MNAMS, 2008). His credentials reflect a deep commitment to rigorous, evidence-based oncology practice.

Dr. Ghadyalpatil's clinical expertise encompasses the full spectrum of solid tumour management, with particular proficiency in immunotherapy, molecular targeted therapy, and biomarker-driven treatment planning. He is skilled in administering chemotherapy regimens across all disease phases—adjuvant, neoadjuvant, and palliative settings—and has advanced knowledge of immune checkpoint inhibitor therapy and hormonally sensitive malignancies. His approach integrates the latest translational research into everyday clinical decision-making, ensuring patients benefit from cutting-edge oncological advances.

International patients, particularly from the Gulf States, Africa, and the broader South Asian region, form a significant part of his practice at Apollo Hospital. Dr. Ghadyalpatil demonstrates exceptional cultural sensitivity and communicates fluently in English, Hindi, and Telugu, making him a reassuring choice for patients navigating complex cancer treatment decisions abroad. He is recognized for his compassionate patient engagement and meticulous attention to individualised care planning.

Apollo Hospital, Jubilee Hills is India's premier multi-specialty tertiary care centre, accredited by NABH and JCI, with world-class infrastructure, dedicated oncology units, and an established international patient services team. The hospital's location in Hyderabad, combined with its reputation for advanced cancer care, makes it an ideal destination for international patients seeking expert oncological management at competitive costs. Dr. Ghadyalpatil's role as an active member of ASCO and ESMO ensures he remains aligned with global best practice standards and continuing medical education.